According to the business intelligence report titled ‘Prefilled Syringes Market Size By Type (Glass, Plastic), By Design (Single-chamber, Dual-chamber), By Applications (Diabetes, Rheumatoid Arthritis, Anaphylaxis, Antithrombotic/Thrombolytic Therapy), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027’, available with Market Study Report, global prefilled syringes market is projected to witness significant growth between 2021-2027.
 

Growing occurrence of chronic diseases such as rheumatoid arthritis and diabetes, rising product adoption to overcome anaphylaxis, and technological developments in dual-chamber design are the key growth drivers for global prefilled syringes market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2484011/
 

For the unversed, a prefilled syringe is a single dose injection with an affixed needle. It is considered as the best choice for unit dose medication.
 

Furthermore, advancements in manufacturing processes and design have allowed leading pharmaceutical companies to raise the lifespan of products and decrease the wastage of drugs, which in turn will facilitate revenue inflow.
 

The utilization of prefilled syringes to help patients while administering their medicines at home instead of going to the hospital which will also stimulate market outlook.
 

As per type, the plastic segment is slated to expand at 13.4% CAGR between 2021-2027 owing to growing consumer preference for plastic prefilled syringes owing to their break resistant and high-solvent nature. Moreover, plastic syringes have a better ergonomic feel, improved robustness, and can support a higher pH range.
 

Speaking of design, the dual chamber segment captured 20% of global prefilled syringes market share in 2020 and is speculated to grow significantly between 2021-2027, primarily due to growing technological advancements.
 

Moving on to application scope, the anaphylaxis segment accrued USD 1 billion in 2020 and is projected to expand substantially between 2021-2027 owing to rising adoption of prefilled syringes among patients.
 

Regionally speaking, Latin America prefilled syringes market is anticipated to record 12.5% CAGR between 2021-2027 owing to growing incidences of chronic diseases.
 

Leading players formulating the competitive landscape of worldwide prefilled syringes industry are West Pharmaceutical Services Inc., Baxter International Inc., Terumo Europe N.V., Becton, Dickinson and Company, Stevanato Group, Catalent Inc., SHL Group, Debiotech S.A., Schott AG, Fresenius Kabi AG, Gerresheimer AG, and Nipro Corporation.